Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI for evidence-based treatment recommendation in oncology: a blinded evaluation of large language models and agentic workflows
0
Zitationen
8
Autoren
2025
Jahr
Abstract
This study demonstrates that while current LLMs show promise in medical decision support, their recommendations require careful clinical supervision to ensure patient safety and optimal care. Further research is needed to improve their clinical use readiness before integration into oncology workflows. These findings provide valuable insights into the capabilities and limitations of LLMs in oncology, guiding future research and development efforts toward integrating AI into clinical workflows.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.245 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.102 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.468 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.429 Zit.
Autoren
Institutionen
- George Washington University(US)
- Bristol-Myers Squibb (United States)(US)
- Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa(ZA)
- University of Washington(US)
- Fred Hutch Cancer Center(US)
- University of North Carolina at Chapel Hill(US)
- Mayo Clinic in Florida(US)
- Shanghai Jiao Tong University(CN)
- Princeton University(US)